Keyphrases
Anastomotic Perfusion
17%
Bile Duct
25%
C57BL
25%
Cell Proliferation
25%
Centromere
25%
Cesarean Section (C-section)
25%
Clinical Course
25%
Clinical Efficacy
18%
Clinical Symptoms
25%
Colorectal Adenocarcinoma
19%
Colorectal Cancer
25%
Diagnostic Biomarker
25%
Diagnostic Work-up
25%
Endoscopic Ultrasound-guided
50%
EUS-guided
25%
Forceps
31%
Gastric Cancer
27%
Gene Copy number
25%
Gene Expression
30%
Glucose Transporter 1 (GLUT1)
25%
Gut Colonization
25%
Gut Microbiota
30%
Hematopoiesis
25%
Heterotopic
25%
Hexokinase
25%
In Cancer
25%
Intraductal Papillary mucinous Neoplasm
25%
Islet
25%
Malignant Potential
21%
Microbiopsy
75%
MicroRNA
25%
MicroRNA Profile
25%
Mode of Delivery
25%
Molecular Biomarkers
25%
Neuroendocrine Tumor
37%
Non-obese Diabetic Mice
25%
Overall Survival
20%
Pancreas
25%
Pancreatic Cancer
17%
Pancreatic Cyst
100%
Poor Prognosis
28%
Prognostic Biomarker
25%
Quantitative Perfusion Assessment
25%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
25%
Sphingolipid Metabolism
25%
Sulfatide
17%
Technical Success
22%
Tumor
25%
Type 1 Diabetes Mellitus (T1DM)
35%
Type I Diabetes
35%
Medicine and Dentistry
Abdominal Cancer
25%
Biopsy Technique
25%
Cesarean Section
25%
Colorectal Carcinoma
25%
Cystic Neoplasm
16%
Cystic Pancreatic Lesion
62%
Cytotechnology
25%
Diagnosis
33%
Dysplasia
18%
Endoscopic Ultrasound
52%
Gastrointestinal Tumor
25%
Glucagon Like Peptide 2
25%
Gut
25%
Gut Microbiota
20%
Heterotopic
25%
Immune System
15%
Immunohistochemistry
28%
Insulin Dependent Diabetes Mellitus
35%
Intraductal Papillary Mucinous Tumor
58%
Macrophage
25%
Mucin 1
25%
Neoplasm
31%
NOD Mice
15%
Pancreas Cyst
25%
Pancreatic Cysts
50%
Periampullary Cancer
25%
Prospective Study
20%
Sphingolipid Metabolism
25%
Sulfatide
17%
Urokinase Receptor
25%
